Compare ETS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETS | EVGN |
|---|---|---|
| Founded | 2020 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Agricultural Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 11.1M |
| IPO Year | 2025 | 2013 |
| Metric | ETS | EVGN |
|---|---|---|
| Price | $1.48 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 304.2K | ★ 319.3K |
| Earning Date | 10-20-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,665,948.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $81.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.57 | N/A |
| 52 Week Low | $0.39 | $0.35 |
| 52 Week High | $2.75 | $1.49 |
| Indicator | ETS | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.97 | 36.93 |
| Support Level | $1.42 | $0.36 |
| Resistance Level | $1.88 | $0.84 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 6.77 | 18.70 |
Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.